Precigen (PGEN) EBIT Margin Growth (1y) (2013 - 2026)
Precigen (PGEN) EBIT Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | 165,923.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 165,923.00 |
| Dec 31, 2025 | 49,735.00 |
| Sep 30, 2025 | 212.25 Mn |
| Jun 30, 2025 | 441,840.00 |
| Mar 31, 2025 | 60,701.00 |
| Dec 31, 2024 | 201,418.00 |
| Sep 30, 2024 | -3.25 Mn |
| Jun 30, 2024 | -729,025.00 |
| Dec 31, 2023 | -293,683.00 |
| Sep 30, 2023 | -209.36 Mn |
| Jun 30, 2023 | -36,522.00 |
| Dec 31, 2022 | -6,719.00 |
| Sep 30, 2022 | 59,390.00 |
| Jun 30, 2022 | -14,284.00 |
| Mar 31, 2022 | -32,967.00 |
| Dec 31, 2021 | 39,895.00 |
| Sep 30, 2021 | -54,841.00 |
| Jun 30, 2021 | -64,830.00 |
| Mar 31, 2021 | -1,653.00 |
| Dec 31, 2020 | 22,231.00 |